Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers.
Daniel Zingg
,
Jinhyuk Bhin
,
Julia Yemelyanenko
,
Sjors M Kas
,
Frank Rolfs
,
Catrin Lutz
,
Jessica K Lee
,
Sjoerd Klarenbeek
,
Ian M Silverman
,
Stefano Annunziato
,
Chang S Chan
,
Sander R Piersma
,
Timo Eijkman
,
Madelon Badoux
,
Ewa Gogola
,
Bjørn Siteur
,
Justin Sprengers
,
Bim de Klein
,
Richard R de Goeij-de Haas
,
Gregory M Riedlinger
,
Hua Ke
,
Russell Madison
,
Anne Paulien Drenth
,
Eline van der Burg
,
Eva Schut
,
Linda Henneman
,
Martine H van Miltenburg
,
Natalie Proost
,
Huiling Zhen
,
Ellen Wientjens
,
Roebi de Bruijn
,
Julian R de Ruiter
,
Ute Boon
,
Renske de Korte-Grimmerink
,
Bastiaan van Gerwen
,
Luis Féliz
,
Ghassan K Abou-Alfa
,
Jeffrey S Ross
,
Marieke van de Ven
,
Sven Rottenberg
,
Edwin Cuppen
,
Anne Vaslin Chessex
,
Siraj M Ali
,
Timothy C Burn
,
Connie R Jimenez
,
Shridar Ganesan
,
Lodewyk F A Wessels
,
Jos Jonkers
More about this publication
Nature
Volume
609
Issue nr.
7929
Pages
E13
Publication date
01-09-2022
Full text links
Publisher website (DOI)
10.1038/s41586-022-05287-8
Europe PubMed Central
36050473
Pubmed
36050473